Continue reading this on our app for a better experience

Open in App
Floating Button
Home News Company in the news

Livingstone to raise $1 mil through placement agreement with SAC Capital

Felicia Tan
Felicia Tan • 2 min read
Livingstone to raise $1 mil through placement agreement with SAC Capital
In a separate statement, Livingstone says the effective date of the proposed listing transfer will be on Feb 4 instead of Jan 28.
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Livingstone Health Holdings (formerly Citicode) says it has received approval by ordinary resolution of the proposed disposal at the extraordinary general meeting (EGM) of the company on Jan 22.

As the proposed disposal has been completed, Citicode-SNAP and Citicode Corporation are no longer subsidiaries or associated companies of the company.

Under the terms of the proposed placement, Livingstone, on Jan 26, entered into a placement agreement with SAC Capital as placement agent in respect of up to 5 million placement shares at the issue price of 20 cents per share.

Under the agreement, Livingstone will pay SAC Capital a placement commission of 3.0% of the issue price multiplied by the total number of placement shares that the latter has sold or procured subscription for.

The completion of the proposed placement is subject to the completion of the acquisition, the completion of the proposed share consolidation, shareholders’ approval and approval in-principle by SGX-ST to list the shares on the Catalist board, among other conditions.

The shares will be issued upon completion of the proposed share consolidation.

See also: Sembcorp issues $350 mil of guaranteed notes due 2036 at 3.65%

The proposed placement will raise up to $1 million in gross proceeds, which will be used to fund the expenses in relation to the proposed transactions.

The total estimated listing expenses comes up to about $1.1 million, which includes professional fees and expenses, placement commission and miscellaneous expenses.

Accordingly, there will be no net proceeds from the proposed placement, and the remaining amount of listing expenses will be funded by Livingstone’s internal resources.

See also: Yangzijiang Shipbuilding subsidiaries have ‘reasonably good prospect of success’ in arbitration claims

In a separate statement, Livingstone says the effective date of the proposed listing transfer will be on Feb 4 instead of Jan 28.

The company has appointed SAC Capital to act as its continuing sponsor.

Shares in Citicode last traded at 0.1 cent.


See: Citicode shareholders approve RTO of Livingstone Health, trading suspension to begin Feb 2 and Citicode to acquire Livingstone Health for $72 mil

Highlights

Re test Testing QA Spotlight
1000th issue

Re test Testing QA Spotlight

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2024 The Edge Publishing Pte Ltd. All rights reserved.